Prognostic Significance of Elevated Platelet Count (>200 x 10^9 per L) in BCLC Stages B and C of Hepatocellular Carcinoma: A Retrospective Multicenter Analysis

Platelet counts showed a stage-dependent prognostic impact in HCC. A platelet count above a cutoff of 200/µL at diagnosis was associated with poorer prognosis. Using this cutoff may improve survival prediction in BCLC B and C patients with potential usage for risk stratification and guidance of treatment decisions. Further external validation is required to confirm these findings and evaluate their clinical applicability.

Authors

Institutions

Publication Details

Journal
Journal of Hepatocellular Carcinoma
Published
2025-05-01
DOI
https://doi.org/10.2147/jhc.s511263
Citations
1
Primary Topic
Inflammatory Biomarkers in Disease Prognosis
Type
article
Field-Weighted Citation Impact
1.05
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Prognostic Significance of Elevated Platelet Count (>200 x 10^9 per L) in BCLC Stages B and C of Hepatocellular Carcinoma: A Retrospective Multicenter Analysis

Florian Paul Reiter, Alexander B. Philipp, Julia V. Mayerle, Najib Ben Khaled et al.
1 citations
Journal of Hepatocellular Carcinoma
Inflammatory Biomarkers in Disease Prognosis
1.05
article

Prognostic Significance of Elevated Platelet Count (>200 x 10^9 per L) in BCLC Stages B and C of Hepatocellular Carcinoma: A Retrospective Multicenter Analysis

Florian Paul Reiter, Alexander B. Philipp, Julia V. Mayerle, Najib Ben Khaled, Christel Weiß, Katharina Pomej, Kathrin Bernhart, Enrico Narciso De Toni, Stefan Munker, Isaac Rodriguez, Daniel Nasseh, Murat Fındık, Lisa Katrin Siegmund, Daniel Roessler, Max Seidensticker, Lorenz Balcar, Liangtao Ye, B Scheiner
article en
1 citations

Abstract

Platelet counts showed a stage-dependent prognostic impact in HCC. A platelet count above a cutoff of 200/µL at diagnosis was associated with poorer prognosis. Using this cutoff may improve survival prediction in BCLC B and C patients with potential usage for risk stratification and guidance of treatment decisions. Further external validation is required to confirm these findings and evaluate their clinical applicability.

Journal of Hepatocellular CarcinomaVol. Volume 12
Heidelberg University (DE), University Hospital Heidelberg (DE), LMU Klinikum (DE), Universitätsklinikum Würzburg (DE), University Medical Centre Mannheim (DE), Medical University of Vienna (AT), Ludwig-Maximilians-Universität München (DE)
Good health and well-being
Openalex Percentile: Top 22%
Inflammatory Biomarkers in Disease Prognosis
1.05
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.